It is possible to freeze a large number of cells at once. Evaluation data from the Kinooka Laboratory at Osaka University is currently available.
"CP-1 High Grade" is a cryoprotectant solution that allows for the cryopreservation of cells such as hematopoietic stem cells and mesenchymal stem cells at -80°C without the use of a programmable freezer. Since it can be cryopreserved without managing the cooling rate, it reduces the time and effort required when freezing large quantities of cells at once. It does not contain animal-derived materials, has confirmed suitability for regenerative medicine product materials, and has undergone non-clinical testing, making it a product with excellent quality and safety. 【Features】 ■ Registered in the Master File (MF) for active pharmaceutical ingredients ■ Manufactured at our GMP-compliant facility in Japan ■ Uses USP-grade DMSO ■ Conducted sterility tests, endotoxin tests, and mycoplasma negative tests ★ You can view the document "Cryopreservation of Human iPS Cells" using evaluation data from the Kinooka Laboratory at Osaka University via "PDF Download." Please feel free to contact us for sample evaluation inquiries.
Inquire About This Product
basic information
"CP-1" was developed as a cryoprotectant for hematopoietic stem cells. Until then, it was difficult to store hematopoietic stem cells except in a programmable freezer, but by using a mixture of hydroxyethyl starch and DMSO, it has made freezing and storage at -80°C possible. It can be used not only for hematopoietic stem cells but also for the cryopreservation of various cell lines, including mesenchymal stem cells and iPS cells. *For more details, please refer to the materials. Feel free to contact us with any inquiries.
Price range
Delivery Time
Applications/Examples of results
*For more details, please refer to the materials. Feel free to contact us as well.*
catalog（6）
Download All Catalogs
Company information
Since its founding, Kyokuto Pharmaceutical Industrial has supported the medical field in protecting human "health" through the manufacture and sale of bacterial culture media, media and reagents for bacterial testing, and clinical testing reagents and equipment. Looking to the future, we are now adding the perspective of "preventive medicine testing" to our traditional focus on "diagnostic and therapeutic testing." Based on the technologies and know-how accumulated in clinical testing, we are also venturing into the fields of cell culture-related products that serve as raw materials for advanced medicine and pharmaceuticals, as well as food and environmental testing, embarking on new challenges.